1932
0

Annual Review of Pharmacology and Toxicology

Volume 58, 2018

A Serendipitous Scientist

Abstract

Growing up in a middle-class Jewish home in the Bronx, I had only one professional goal: to become a physician. However, as with most of my Vietnam-era MD colleagues, I found my residency training interrupted by the Doctor Draft in 1968. Some of us who were academically inclined fulfilled this obligation by serving in the US Public Health Service as commissioned officers stationed at the National Institutes of Health. This experience would eventually change the entire trajectory of my career. Here I describe how, over a period of years, I transitioned from the life of a physician to that of a physician-scientist; my 50 years of work on cellular receptors; and some miscellaneous thoughts on subjects as varied as Nobel prizes, scientific lineages, mentoring, publishing, and funding.

Keyword(s): autobiography, G protein, GPCR, HHMI, lineages, mentoring, Nobel Prize
Loading

Article metrics loading...

/content/journals/10.1146/annurev-pharmtox-010617-053149
2018-01-06
2025-06-20
Loading full text...

Full text loading...

/deliver/fulltext/pharmtox/58/1/annurev-pharmtox-010617-053149.html?itemId=/content/journals/10.1146/annurev-pharmtox-010617-053149&mimeType=html&fmt=ahah

Literature Cited

  1. Berry FB. 1.  1976. The story of “The Berry Plan. .” Bull. N. Y. Acad. Med. 52:3278–82 [Google Scholar]
  2. Lefkowitz RJ, Roth J, Pricer W, Pastan I. 2.  1970. ACTH receptors in the adrenal: specific binding of ACTH-125I and relation to adenyl cyclase. PNAS 65:3745–52 [Google Scholar]
  3. Lefkowitz RJ, Roth J, Pastan I. 3.  1970. Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma. Science 170:3958633–35 [Google Scholar]
  4. Lefkowitz RJ, Roth J, Pastan I. 4.  1970. Effects of calcium on ACTH stimulation of the adrenal: separation of hormone binding from adenyl cyclase activation. Nature 228:5274864–66 [Google Scholar]
  5. Goldstein JL, Brown MS. 5.  2012. History of science: a golden era of Nobel laureates. Science 338:61101033–34 [Google Scholar]
  6. Ahlquist RP. 6.  1973. Adrenergic receptors: a personal and practical view. Perspect. Biol. Med. 17:1119–22 [Google Scholar]
  7. Sutherland EW, Robison GA. 7.  1966. The role of cyclic-3′,5′-AMP in responses to catecholamines and other hormones. Pharmacol. Rev. 18:145–61 [Google Scholar]
  8. Lefkowitz RJ, Stadel JM, Caron MG. 8.  1983. Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu. Rev. Biochem. 52:159–86 [Google Scholar]
  9. Lefkowitz RJ, Stadel JM, Cerione RA, Strulovici B, Caron MG. 9.  1984. Structure and function of beta-adrenergic receptors: regulation at the molecular level. Adv. Cycl. Nucleotide Protein Phosphorylation Res. 17:19–28 [Google Scholar]
  10. Gilman AG. 10.  1987. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:615–49 [Google Scholar]
  11. Cerione RA, Sibly DR, Codina J, Benovic JL, Winslow J. 11.  et al. 1984. Reconstitution of a hormone-sensitive adenylate cyclase system: the pure β-adrenergic receptor and guanine nucleotide regulatory protein confer hormone responsiveness on the resolved catalytic unit. J. Biol. Chem. 259:9979–82 [Google Scholar]
  12. May DC, Ross EM, Gilman AG, Smigel MD. 12.  1985. Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J. Biol. Chem. 260:2915829–33 [Google Scholar]
  13. De Lean A, Stadel JM, Lefkowitz RJ. 13.  1980. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:157108–17 [Google Scholar]
  14. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. 14.  1993. A mutation-induced activated state of the β2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268:74625–36 [Google Scholar]
  15. Hancock AA, De Lean AL, Lefkowitz RJ. 15.  1979. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. Mol. Pharmacol. 16:11–9 [Google Scholar]
  16. Dixon RAF, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG. 16.  et al. 1986. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 321:606575–79 [Google Scholar]
  17. Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U. 17.  et al. 1987. Cloning, sequencing, and expression of the gene coding for the human platelet α2-adrenergic receptor. Science 238:4827650–56 [Google Scholar]
  18. Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, Kobilka BK. 18.  1988. Molecular cloning and expression of the cDNA for the hamster α1-adrenergic receptor. PNAS 85:197159–63 [Google Scholar]
  19. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. 19.  1991. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653–88 [Google Scholar]
  20. Stadel JM, Nambi P, Shorr RGL, Sawyer DF, Caron MG, Lefkowitz RJ. 20.  1983. Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the β-adrenergic receptor. PNAS 80:113173–77 [Google Scholar]
  21. Pitcher JA, Freedman NJ, Lefkowitz RJ. 21.  1998. G protein–coupled receptor kinases. Annu. Rev. Biochem. 67:653–92 [Google Scholar]
  22. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. 22.  1990. β-Arrestin: a protein that regulates β-adrenergic receptor function. Science 248:49621547–50 [Google Scholar]
  23. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J. 23.  et al. 1992. β-Arrestin2, a novel member of the arrestin/β-arrestin gene family. J. Biol. Chem. 267:2517882–90 [Google Scholar]
  24. Kühn H, Wilden U. 24.  1987. Deactivation of photoactivated rhodopsin by rhodopsin-kinase and arrestin. J. Recept. Res. 7:1–4283–98 [Google Scholar]
  25. Benovic JL, Kühn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ. 25.  1987. Functional desensitization of the isolated β-adrenergic receptor by the β-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). PNAS 84:248879–82 [Google Scholar]
  26. Zhang J, Ferguson SSG, Barak LS, Ménard L, Caron MG. 26.  1996. Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J. Biol. Chem. 271:3118302–5 [Google Scholar]
  27. Goodman OB Jr., Krupnick JG, Santini F, Gurevich VV, Penn RB. 27.  et al. 1996. β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor. Nature 383:6599447–50 [Google Scholar]
  28. Luttrell LM, Ferguson SSG, Daaka Y, Miller WE, Maudsley S. 28.  et al. 1999. β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283:5402655–61 [Google Scholar]
  29. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME. 29.  et al. 2000. β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:54961574–77 [Google Scholar]
  30. Xiao K, McClatchy DB, Shukla AK, Zhao Y, Chen M. 30.  et al. 2007. Functional specialization of β-arrestin interactions revealed by proteomic analysis. PNAS 104:2912011–16 [Google Scholar]
  31. Xiao K, Sun J, Kim J, Rajagopal S, Zhai B. 31.  et al. 2010. Global phosphorylation analysis of β-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). PNAS 107:3415299–304 [Google Scholar]
  32. Christensen GL, Kelstrup CD, Lyngsø C, Sarwar U, Bøgebo R. 32.  2010. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol. Cell Proteom. 9:71540–53 [Google Scholar]
  33. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. 33.  2001. Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin. Science 294:55451307–13 [Google Scholar]
  34. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L. 34.  et al. 2003. Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. PNAS 100:1910782–87 [Google Scholar]
  35. Rajagopal S, Rajagopal K, Lefkowitz RJ. 35.  2010. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9:5373–86 [Google Scholar]
  36. Rajagopal S, Bassoni DL, Campbell JJ, Gerard NP, Gerard C, Wehrman TS. 36.  2013. Biased agonism as a mechanism for differential signaling by chemokine receptors. J. Biol. Chem. 288:4935039–48 [Google Scholar]
  37. Shukla AK, Manglik A, Kruse AC, Xiao K, Reis RI. 37.  et al. 2013. Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497:7447137–41 [Google Scholar]
  38. Shukla AK, Westfield GH, Xiao K, Reis RI, Huang LY. 38.  et al. 2014. Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature 512:7513218–22 [Google Scholar]
/content/journals/10.1146/annurev-pharmtox-010617-053149
Loading
A Serendipitous Scientist
Annual Review of Pharmacology and Toxicology 58, 17 (2018); https://doi.org/10.1146/annurev-pharmtox-010617-053149
/content/journals/10.1146/annurev-pharmtox-010617-053149
/content/journals/10.1146/annurev-pharmtox-010617-053149
Loading

Data & Media loading...

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error